Oramed Pharmaceuticals, Inc. (ORMP)

3.22 +0.05 (+1.58%) USD  |  NASDAQ  |  Feb 20, 16:00
3.23 +0.01 (+0.31%) After-Hours: 20:00
More

Oramed Pharmaceuticals SG&A Expense (Quarterly) : 1.274M for Sept. 30, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ORMP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Lifeward Ltd. 5.126M
Bristol Myers Squibb Co. 2.181B
Merck & Co., Inc. 2.898B
Instil Bio, Inc. 5.895M
Moderna, Inc. 308.00M